In This Section

Newsroom

  • Sara Jane Ward

    With New NIH Small Business Innovation Research Award, Temple Researchers Set to Test Novel Cannabis Analog in Preclinical Studies

    Thanks to a new Phase 2 Small Business Innovation Research (SBIR) award from the National Institutes of Health, Temple researchers have the opportunity to further explore the therapeutic potential of a CBD analog known as KLS-13019.

  • cerezo-maddah

    Student Spotlight: Juan Cerezo and Malek Maddah

    When asked to describe their life journeys, Lewis Katz School of Medicine students Juan Cerezo and Malek Maddah tell stories that are eerily similar.

  • teac-philly-airport.png

    Lewis Katz School of Medicine Students Step Up to Assist Afghanistan Evacuees

    When leaders of the Temple Emergency Action Corps (TEAC) learned that flights carrying Afghan evacuees would be arriving soon at the Philadelphia International Airport, the students at the Lewis Katz School of Medicine sprang into action to do what they do best – to lend a hand wherever they were needed.

  • PA White Coat

    White Coat Ceremony Marks Symbolic Moment for Physician Assistant Students

    For the members of the Physician Assistant Program class of 2023, the White Coat Ceremony represents an important transition, a significant milestone in their education. It means they are about to begin applying their medical knowledge in clinical settings. 

  • Glenn

    Common Pain Reliever Safe for Use in Children with Inherited Blood Cell Disorder, New Study by Temple Researchers Shows

    Infection is the most common cause of hemolysis in G6PD-deficient individuals, but certain foods and medications may precipitate the destruction of blood cells, especially in children. Ibuprofen, commonly used for pain relief in pediatric medicine, is included on the list of suspected hemolysis-inducing drugs in G6PD-deficient children. But a recent literature review by researchers at the Lewis Katz School of Medicine suggests that it should be removed from the list – ibuprofen very rarely causes hemolytic anemia in children with G6PD deficiency.

  • Steven Popoff

    Faculty Spotlight: Dr. Steven N. Popoff

    Three years ago, after decades of basic science research into the cell and molecular mechanisms involved in the development of skeletal tissues, Steven N. Popoff, PhD, began to scale back his research and pivot toward full-time teaching. Not long afterward, students chose him for a Golden Apple teaching award. And this spring, he won a coveted Lindback Foundation Award for Distinguished Teaching, the highest recognition for excellence in teaching at Temple University.

  • Bashir

    Anatomic Compression of Iliac Vein Major Factor in Pulmonary Vascular Disease, Temple Researchers Report

    In many cases, the clots that cause CTEPH come from veins in the lower half of the body, usually due to deep vein thrombosis (DVT). A risk factor for DVT is compression of the iliac vein in the pelvis, which can be caused by an anatomical variant known as May-Thurner anatomy (MTA). While MTA is generally thought to be rare, a new study by researchers at the Lewis Katz School of Medicine shows that the anomaly is very common in patients with CTEPH – in a sample of 148 patients referred to Temple’s CTEPH program since 2016, nearly 30 percent were found to have MTA.

  • Drs. Khalili and Burdo - HIV Research

    Temple Researchers Take Another Step Toward Curing HIV

    In 2014, Temple University researchers proved they could use state-of-the-art molecular scissors to cut out dormant HIV hiding in human cells in lab dishes. Now, seven years later — the blink of an eye in basic research — the approach has received Food and Drug Administration approval for testing in humans, buoying hopes for curing, not just suppressing, the insidious virus that causes AIDS. Although the world is focused on the COVID-19 pandemic, HIV/AIDS continues to rage in many poor countries 40 years after it was identified.

Pages